Practical Radiation Oncology

PRO 02 - Brain Metastases Radiotherapy while Mitigating Radionecrosis and Neurotoxicity

Moderator(s)

• 

  Avani Rao, MD

  Radiation Oncology Associates
  Fairfax, VA, United States
• 

  Beant Gill, MD

  Associates in Radiation Medicine
  Waldorf, MD

This session will be divided into 3 subsections:
1) Updates on brain met management: Discussion of selecting patients for HA-WBRT and SRS including a good amount of dialogue on developing concepts in pre- and post-op radiosurgery (who to consider for what sequence, dose and planning considerations).
2)Neurocognitive preservation: What does it actually mean to patients (tips on counseling, any supportive resources), differences with SRS vs. whole brain, memantine (role, considerations when prescribing, taper), hippocampal avoidance (how to and planning), role for additional substructure sparing.
3) Radionecrosis: Prevention strategies for intact brain mets (dose/fraction, technique/platform considerations, composite dosing or serial treatment days), diagnosis tools (PET, rCBV), and management (Avastin, LITT, excision, etc).

Presentations:

• 9:30 AM – 9:32 AM ET

  Introductions
  

  Speaker: Avani Rao, MD – Radiation Oncology Associates
• 9:32 AM – 9:52 AM ET

  Tailored Approach to Brain Metastases Management
  

  Speaker: Stuart Burri, MD – Levine Cancer Institute
• 9:52 AM – 10:12 AM ET

  Mitigating and Managing Neurotoxicity from Radiotherapy for Brain Metastases
  

  Speaker: William Breen, MD – Mayo Clinic Rochester
• 10:12 AM – 10:32 AM ET

  Prevention and Management Strategies for Radionecrosis
  

  Speaker: Raj Singh, MD – The Ohio State University Wexner Medical Center
• 10:32 AM – 10:45 AM ET

  Questions and Answers
  

  Speaker: Beant Gill, MD – Associates in Radiation Medicine